Red cell distribution width and prognosis in myelofibrosis patients treated with ruxolitinib.

Autor: Cattaneo D; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Myeloproliferative Syndromes Unit, Via Francesco Sforza 35, Milan, 20122, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Galli N; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Myeloproliferative Syndromes Unit, Via Francesco Sforza 35, Milan, 20122, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Bucelli C; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Myeloproliferative Syndromes Unit, Via Francesco Sforza 35, Milan, 20122, Italy., Fidanza CA; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Myeloproliferative Syndromes Unit, Via Francesco Sforza 35, Milan, 20122, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Bellani V; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Myeloproliferative Syndromes Unit, Via Francesco Sforza 35, Milan, 20122, Italy., Artuso S; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Myeloproliferative Syndromes Unit, Via Francesco Sforza 35, Milan, 20122, Italy., Bianchi P; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Myeloproliferative Syndromes Unit, Via Francesco Sforza 35, Milan, 20122, Italy., Consonni D; Epidemiology Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Passamonti F; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Myeloproliferative Syndromes Unit, Via Francesco Sforza 35, Milan, 20122, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Iurlo A; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Myeloproliferative Syndromes Unit, Via Francesco Sforza 35, Milan, 20122, Italy. alessandra.iurlo@policlinico.mi.it.

Publikováno v: Annals of hematology [Ann Hematol] 2024 Aug; Vol. 103 (8), pp. 2787-2795. Date of Electronic Publication: 2024 Jun 12.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Trend of circulating CD34 ⁺ cells in patients with myelofibrosis: Association with spleen response during ruxolitinib treatment.

Autor: Iurlo A; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Galli N; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Bucelli C; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Artuso S; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Consonni D; Epidemiology Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Cattaneo D; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.

Publikováno v: British journal of haematology [Br J Haematol] 2023 Feb; Vol. 200 (3), pp. 315-322. Date of Electronic Publication: 2022 Oct 20.

Stamen dimorphism in bird-pollinated flowers: Investigating alternative hypotheses on the evolution of heteranthery.

Autor: Dellinger AS; Department of Botany and Biodiversity Research, University of Vienna, Vienna, Austria., Artuso S; Department of Biosciences, University of Salzburg, Salzburg, Austria., Fernández-Fernández DM; Instituto Nacional de Biodiversidad, Quito, Ecuador., Schönenberger J; Department of Botany and Biodiversity Research, University of Vienna, Vienna, Austria.

Publikováno v: Evolution; international journal of organic evolution [Evolution] 2021 Oct; Vol. 75 (10), pp. 2589-2599. Date of Electronic Publication: 2021 May 19.

Case report: Transfusion independence and abolition of extravascular hemolysis in a PNH patient treated with pegcetacoplan.

Autor: Fattizzo B; Department of Oncology and Oncohematology, University of Milan, Milan, Italy.; Hematology Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Versino F; Department of Oncology and Oncohematology, University of Milan, Milan, Italy.; Hematology Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Zaninoni A; Hematology Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Marcello APML; Hematology Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Vercellati C; Hematology Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Artuso S; Hematology Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Barcellini W; Hematology Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Publikováno v: Frontiers in immunology [Front Immunol] 2022 Dec 01; Vol. 13, pp. 1060923. Date of Electronic Publication: 2022 Dec 01 (Print Publication: 2022).